Abatacept

Details

Files

Generic Name:

Abatacept

Project Status:

Complete

Therapeutic Area:

Arthritis, Juvenile Idiopathic & Juvenile Rheumatoid

Manufacturer:

Bristol-Myers Squibb Canada

Brand Name:

Orencia

Project Line:

Reimbursement Review

Project Number:

SR0145-000

Performance Metric:

N/A — Predated performance metrics

Submission Type:

Initial

Indications:

Arthritis, Juvenile Idiopathic & Juvenile Rheumatoid

Recommendation Type:

List with clinical criteria and/or conditions

Final Recommendation:

April 22, 2009

Last Updated : August 29, 2008